Imagine seeing the intricate details of a toothpick’s cross-section or the tiny brain of an insect—all revealed with stunning clarity. This is the power of The University of Queensland’s (UQ) cutting-edge micro-CT scanner, a 7-tonne marvel that’s pushing the boundaries of research and innovation. But here’s where it gets even more fascinating: this technology isn’t just for scientists in ivory towers. It’s a game-changer for industries ranging from agriculture to advanced manufacturing, and it’s sparking conversations about what’s possible when we can see the world at a micron level.
Associate Professor Gary Cowin, a National Imaging Facility Fellow at UQ’s Australian Institute for Bioengineering and Nanotechnology (AIBN), is at the forefront of showcasing the scanner’s capabilities. Through striking images of everyday objects like toothpicks and matchsticks, as well as complex biological structures like insect brains, Dr. Cowin highlights the scanner’s versatility. ‘The level of detail is incredible,’ he says. ‘It’s not just about visualization—it’s about unlocking scientific and commercial potential.’
The Yxlon FF35 micro-CT scanner is a powerhouse, capable of handling samples as small as 1mm and as large as 400mm. This makes it an invaluable tool across disciplines. For instance, agricultural researchers have used it to study root growth in different soil conditions, while materials scientists and engineers have assessed carbon fiber porosity and verified 3D-printed components. ‘We’ve scanned everything from mining ore samples to praying mantis brains,’ Dr. Cowin notes. And this is the part most people miss: the scanner’s color-enhanced images reveal hidden cellular structures in vivid detail, making it as much an art form as a scientific tool.
But here’s the controversial part: as this technology becomes more accessible, it raises questions about its ethical use. Should industries prioritize high-resolution imaging for quality control, or could this lead to over-reliance on technology at the expense of traditional methods? Dr. Cowin emphasizes accessibility, offering scanning services and training to researchers and commercial partners alike. ‘The idea is for the technology to be as accessible as possible,’ he says. But what does this mean for smaller labs or developing countries that may not have the resources to leverage such advanced tools?
The scanner is part of a broader suite of research capabilities at UQ’s AIBN, including human imaging, pre-clinical MRI, and molecular imaging. Funded by contributions from the National Imaging Facility (NIF), the Queensland State Government, and UQ, this technology is a testament to collaborative innovation. Yet, it also invites debate: are we doing enough to ensure equitable access to such groundbreaking tools?
As we marvel at the images produced by this micro-CT scanner, it’s worth asking: How will this technology reshape industries, and what responsibilities come with its power? Share your thoughts in the comments—let’s spark a conversation about the future of imaging and its impact on science, industry, and society.
